Immucell (ICCC) EBITDA Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Immucell (ICCC) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 136.00 |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -368.00 |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 40.00 |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 323.00 |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 1,809.00 |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,809.00 |
| Dec 31, 2025 | -878.00 |
| Sep 30, 2025 | 993.00 |
| Jun 30, 2025 | 3,417.00 |
| Mar 31, 2025 | 1,799.00 |
| Sep 30, 2024 | 1,238.00 |
| Jun 30, 2024 | 1,159.00 |
| Mar 31, 2024 | 6,132.00 |
| Sep 30, 2023 | -908.00 |
| Jun 30, 2023 | -2,090.00 |
| Mar 31, 2023 | -7,497.00 |
| Dec 31, 2022 | -4,445.00 |
| Sep 30, 2022 | -1,812.00 |
| Jun 30, 2022 | -2,078.00 |
| Mar 31, 2022 | 1,863.00 |
| Dec 31, 2021 | 1,962.00 |
| Sep 30, 2021 | 1,202.00 |
| Jun 30, 2021 | 2,805.00 |
| Mar 31, 2021 | -1,313.00 |
| Dec 31, 2020 | -1,027.00 |